Merck licenses new and improved methods for developing antibiotics from San Diego State University

NewsGuard 100/100 Score

Two new and improved methods of developing antibiotics discovered at San Diego State University have been licensed to Merck Pharmaceuticals for $300,000, the largest technology transfer agreement so far for SDSU.

The technology, which uncovered hundreds of new essential genes and greatly enhances the ability to target those genes for new antibiotics, was developed by SDSU researchers Judith Zyskind and R. Allyn Forsyth. Zyskind, a professor at the time of the discoveries, is the director of the SDSU BioScience Center. Forsyth was a graduate student at the time of the discoveries and is now a Merck employee.

The license agreement gives Merck exclusive use of the technology for four years with a renewable option. SDSU still holds the two patents for the technology, and SDSU faculty and students also can use the technology for their projects.

“The emergence and global dissemination of antibiotic resistant pathogens has led to people dying from infectious diseases,” Zyskind said. “These discoveries strengthen the arsenal against infectious diseases by hastening the arrival of the next generation of antibiotics.”

Merck negotiated the license agreement through SDSU’s Technology Transfer Service Office. The SDSU Foundation established it in 1998 to facilitate and enhance the transfer of intellectual property, resources and information between the university and the private sector.

“The agreement with Merck is a perfect example of how sharing new, university-based technologies with forward-thinking businesses leads to advances that improve our lives – in this case in health care,” said Barry Janov, director of the SDSU technology transfer program.

Zyskind said BioScience Center researchers will use the technology to further investigate the emerging link between infectious diseases and the nation’s No. 1 killer – heart disease.

“Diseases such as athlerosclerosis and diabetes have been thought to result from lifestyle and genetic factors, but the latest information shows infectious diseases may be a significant risk factor,” Zyskind said. “That means developing new antibiotics could become more important for preventing disease in the future.”


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Genes dictate taste: Study finds genetic links to food preferences